Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I don't think they need a grant. Probability and Statistics, Inc. is involved in multiple projects with Seafarer (SFRX). I spoke with the CEO of P&S, these projects include development of sensor technology, computational simulations, signal analysis, prototyping, assorted engineering services, and doing directed research.
I already loaded back up, just a bit ago. I love a sale.
Indeed! I made over 300% first time around.
I didn't realize the "Short & Distort" comedy hour began so early?
Indeed!
I have added more to my holdings of KALY Long position, in spite of the "Short & Distort" comedy hour.
I have added more to my holdings SFRX LONG position, in spite of the "Short & Distort" comedy hour.
Government rules and laws, not mine.
well, "they" beat it down below the support level.
It's a long shot, but if they did a TV special on Seafarer's activities, you couldn't keep this stock down. That would probably even bring comments on the financial programs. It is of a technology and story line that could bring that, IMO.
In this case, I know no more than the rest of you. BUT, Even under FOIA, let alone the Feds and states they (government) have numerous reasons not to release.
Exemption 1: Information that is classified to protect national security.
Exemption 2: Information related solely to the internal personnel rules and practices of an agency.
Exemption 3: Information that is prohibited from disclosure by another federal law.
Exemption 4: Trade secrets or commercial or financial information that is confidential or privileged. and many more...
Government contract specifics are often not disclosed. Though we have made progress on spending transparency over the last decade, current contract disclosure standards remain inadequate to allow substantive evaluations of individual spending decisions.
This is because the federal government does not proactively post the documents related to government contracts as a part of standard spending transparency disclosures.
While the federal government has several times considered establishing a policy to proactively post contracts, the step has never been taken.
Both ways!
One Penny sale going on!
running like a scalded dog out the gate!
No surprise that there was profit taking in SFRX after a +400% run in a month. Looking at the chart it appears we are at a support level now. Some consolidating and leaning south.
Below here is a very strong support at about 1 cent. Resistance is up at about 2 cents until we break it. The longer term trend looks to be still good, on a short term, perhaps the trend is on the weak side. IMO Long term MAs good. Probably oversold too.
I think the smart money may move in quickly and not wait for the lower level. We may oscillate in the morning between those points, look at your level 2 in the morning and see how its stacks up. BUT we have the marketmaker(s) to contend with, and I can not read their minds or check their pockets.
IMO, we will retrace soon, and break through 2 resistance. If not, I love a sale and would be shopping at the one penny store. Check it out yourself, know where you are heading before you start.
In most cases you do not "make" CBD, it's naturally occurring. Although, I believe it can be synthetic too. Personally, I am only aware of a couple of methods to extract the naturally occurring compounds called cannabinoids. It's actually called Cannabidiol, the CBD we are interested in are in the industrial hemp plant or the cannabis as well.
The FDA and the Feds for legality purposes, seem to be drawing the line at CBD containing less than .3% THC. Versus a THC product.
CBD can be extracted from the plants. Ethanol and C02 extraction are two commonly used methods for extracting CBD and are the cleanest ways to extract CBD for human consumption.
CO2 extraction uses filters and pressure, most common and cheap. Ethanol extraction is used for a more high volume approach. There are additional steps if higher purification is needed, which I am not familiar with personally. The additional steps (heating is involved) on the oil are necessary for human consumption and use, for example.
There's plenty of interest in this stock and the company. I currently have a lot of wonderful stocks in my portfolio. Yet, FTEG has the most potential. It is rare to find a micro penny that meets the basic fundamental aspects to go forward. To just break above just one cent and rise from there. You won't find this multiplier or leverage in most stocks worth your time. IMO
There are many different styles of traders here, with different time horizons and goals. You will hear many opinions, pending personal goals. Making 20%, 30% is child's play. Making a +100% is not much of a challenge either. However, making those multi +1000% plays are always so sweet. What trader does not enjoy a 25x return on their money?
I think if we can poke our head above .02 now and hold it, .025 is not far off at all, IMO
Simply another fundamental and technical aspect. One only need be on the right side of the trade.
There are countless stocks than trade higher and higher on a lot more fluff than here! Even Blue Chip IPOs that raise a billon, with no assets as people pay $75 a share on promises and debt. Stocks that trade hundreds of dollars and have not made a profit in many years, or no profit ever.
No where in the market can you realize this kind of leverage, that we see everyday in the micro pennies. We bet on the come, just as most do. However, the rewards here cannot be had anywhere else! IMO
SFRX has increased in value by over +400% over the last month or so! Many short term investors have been waiting to take profits, I'm surprised the correction did not occur sooner. Once the technicals confirmed the start, it is soon confirmed, which triggers the profit taking pivot as a decision is made by many more.
It hit its support level and already has made a bounce as traders re-enter. Also an opportunity to add, or get in for those waiting on the side lines. IMO. All depends on your time line and style; day trader, swing trade, mid term, long term, etc. Many ways to profit.
For all of us, it is important to understand with most things in life, including stocks, it's our perception that transforms into our reality. As complex as stocks can be, with the endless variables of both technical and fundamental data to evaluate, it will often come down to that.
Everyone has their own filtering system, so results are often different. SFRX has a good story and they tell it well. We are betting on what the results can be, that's why it's mere pennies now. Due to the type of story, it will be told around the world. Again, the source of the story matters not, only that it is told and effect remains the same.
KALY getting more attention!
https://pennystocks.com/penny-stock-news/2019/04/09/top-5-hot-penny-stocks-to-watch-in-april/
Hemp, CBD, and Cannabis stocks, both medical and recreational will be using the next week or two Nation-Wide 4-20 Events to promote new products and services.
Stocks like FTEG, and others are using this to add more exposure and momentum to the business.
It's been a great year for progressive cannabis reform and advancing Cannabis and Hemp. As 4/20 approaches in 2019, There are tons of cannabis events and Investment events happening around 4/20 this year.
https://potguide.com/guides/travel-guides/420-guides/420-events-guide/
https://potguide.com/california/marijuana-events/event/2019-04-15/california-hemp-investment-forum/
https://www.coloradopotguide.com/what-to-do/marijuana-activities/
https://potguide.com/canada/
Hemp, CBD, and Cannabis stocks, both medical and recreational will be using the next week or two Nation-Wide 4-20 Events to promote new products and services.
Stocks like GDET, with The Greenery and others are using this to add more exposure and momentum to the business.
It's been a great year for progressive cannabis reform and advancing Cannabis and Hemp. As 4/20 approaches in 2019, There are tons of cannabis events and Investment events happening around 4/20 this year.
https://potguide.com/guides/travel-guides/420-guides/420-events-guide/
https://potguide.com/california/marijuana-events/event/2019-04-15/california-hemp-investment-forum/
https://www.coloradopotguide.com/what-to-do/marijuana-activities/
https://potguide.com/canada/
Hemp, CBD, and Cannabis stocks, both medical and recreational will be using the next week or two Nation-Wide 4-20 Events to promote new products and services.
Stocks like KALY and others will be using this to add more exposure and momentum to the business.
It's been a great year for progressive cannabis reform and advancing Cannabis and Hemp. As 4/20 approaches in 2019, There are tons of cannabis events and Investment events happening around 4/20 this year.
https://potguide.com/guides/travel-guides/420-guides/420-events-guide/
https://potguide.com/california/marijuana-events/event/2019-04-15/california-hemp-investment-forum/
https://www.coloradopotguide.com/what-to-do/marijuana-activities/
https://potguide.com/canada/
If the Shorts are wrong on KALY, and the daily trend continues there will be soon, a rush to cover. Which would in turn add to the upward movement. Considering the news is going to continue and 4-20 coming as well... IMO.
If you're a flipper, don't matter.
Could hit .02 today, daily flippers have been consistent taking profits, which should be about that level as well.IMO
Fundamentally, less float requires less volume to move it. I would imagine the company wants to increase the PPS and with the new direction take the steps to accomplish that. IMO
Back a few months ago, FTEG ran past 1 cent in one weeks time. That's over 25x the current Ask.
We all know the penny Pink stocks play many games; Mms as well, many companies included. I believe the company has committed to enough positive activities to continue for some time.
Personally, I am going to ride along. Most stocks in this position have broke through to pennies. I'm not concerned with the moment to moment flippers, we all have our time horizons.
Personally, I would suspect the volume and buyers of Seafarers (SFRX) come from many non-traditional penny stock investors.
Millions of everyday people have been exposed to the treasure and historical findings. Let alone the great exposure by national, even worldwide news. In addition, the academic and scientific communities, plus many from the Florida activities. The perceived potential payout from something you can buy now for pennies could be quite a payday for many.
Update, this weekend, Per CEO of P&S who is the firm working with Seafarer (SFRX), "Probability and Statistics, Inc. is involved in multiple projects with Seafarer."
"These projects include development of sensor technology, computational simulations, signal analysis, prototyping, assorted engineering services, and doing directed research."
Intentions of the government continue to appear positive, in establishing guidelines on CBD and Hemp in general, which is also a positive for FTEG, IMO.
FDA Commissioner Dr. Scott Gottleib provided testimony to the House Committee on Appropriations on the FDA’s status of operations. According to Gottleib, the FDA understands that “Congress wants there to be a pathway for CBD to be available.”
In his testimony on enforcement priorities, Gottlieb acknowledged that Congress intended to legalize industrial hemp and its derivatives via the 2018 Farm Bill. Time will tell if those propositions pay off, but they look pretty good right now — at least from an FDA enforcement perspective. Norman “Ned” Sharpless to be FDA acting Commissioner when Gottleib leaves this month.
Norman Sharpless will take over the top FDA post to be vacated by Scott Gottlieb, who also seemed generally friendly to (CBD) dietary supplements. Industry leaders expect little change from current views to move this forward quickly.
Yes, the Texas Department of State Health Services has removed hemp from its list of dangerous drugs like cocaine and heroin, in effect making it legal to use, buy, sell and possess the plant and the CBD oil extracted from it in Texas.
Intentions of the government continue to appear positive, in establishing guidelines on CBD and Hemp in general, which is also a positive for GDET, IMO.
FDA Commissioner Dr. Scott Gottleib provided testimony to the House Committee on Appropriations on the FDA’s status of operations. According to Gottleib, the FDA understands that “Congress wants there to be a pathway for CBD to be available.”
In his testimony on enforcement priorities, Gottlieb acknowledged that Congress intended to legalize industrial hemp and its derivatives via the 2018 Farm Bill.
Time will tell if those propositions pay off, but they look pretty good right now — at least from an FDA enforcement perspective. Norman “Ned” Sharpless to be FDA acting Commissioner when Gottleib leaves this month.
Norman Sharpless will take over the top FDA post to be vacated by Scott Gottlieb, who seemed generally friendly to (CBD) dietary supplements. Industry leaders expect little change from current views to move this forward quickly.
Intentions of the government continue to appear positive, in establishing guidelines on CBD and Hemp in general, which is also a positive for IGPK, IMO.
FDA Commissioner Dr. Scott Gottleib provided testimony to the House Committee on Appropriations on the FDA’s status of operations. According to Gottleib, the FDA understands that “Congress wants there to be a pathway for CBD to be available.”
In his testimony on enforcement priorities, Gottlieb acknowledged that Congress intended to legalize industrial hemp and its derivatives via the 2018 Farm Bill.
Time will tell if those propositions pay off, but they look pretty good right now — at least from an FDA enforcement perspective. Norman “Ned” Sharpless to be FDA acting Commissioner when Gottleib leaves this month.
Norman Sharpless will take over the top FDA post to be vacated by Scott Gottlieb, who seemed generally friendly to (CBD) dietary supplements. Industry leaders expect little change from current views to move this forward quickly.
Intentions of the government continue to appear positive, in establishing guidelines on CBD and Hemp in general, which is also a positive for KALY, IMO.
FDA Commissioner Dr. Scott Gottleib provided testimony to the House Committee on Appropriations on the FDA’s status of operations. According to Gottleib, the FDA understands that “Congress wants there to be a pathway for CBD to be available.”
In his testimony on enforcement priorities, Gottlieb acknowledged that Congress intended to legalize industrial hemp and its derivatives via the 2018 Farm Bill.
Time will tell if those propositions pay off, but they look pretty good right now — at least from an FDA enforcement perspective. Norman “Ned” Sharpless to be FDA acting Commissioner when Gottleib leaves this month.
Norman Sharpless will take over the top FDA post to be vacated by Scott Gottlieb, who seemed generally friendly to (CBD) dietary supplements. Industry leaders expect little change from current views to move this forward quickly.
I've noticed many MMs put up nonsense bid/ask numbers after the close. Check them in the morning at opening.
This is a no-brainer folks! KALY has the potential to go in many directions. Companies with a decent business plan and structure in the Hemp or Cannabis industry, both medical and recreational are going to explode in the near term, IMO.
Colorado has already proved that the industry can produce the one thing the State and Federal governments always want. Recent numbers have revealed taxes collected on sales are more than DOUBLE that of alcohol.
Sales in Colorado exceeded $1 billion as of August last year, with tax revenue from those sales coming in at over $200 million, according to a report from the Colorado Department of Revenue. Broke states want those new TAX revenues.
It's a money-grab for taxes at state levels with many on board and others lined up. It won't be long before the feds want their piece of the pie too. Canada already made the jump, the US is bound to follow soon, IMO.